Juan Horcajada to Pseudomonas Infections
This is a "connection" page, showing publications Juan Horcajada has written about Pseudomonas Infections.
Connection Strength
1.706
-
Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical. J Infect. 2019 09; 79(3):253-261.
Score: 0.552
-
Colistin Use in Patients with Chronic Kidney Disease: Are We Underdosing Patients? Molecules. 2019 Feb 01; 24(3).
Score: 0.537
-
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa. BMC Infect Dis. 2017 01 05; 17(1):11.
Score: 0.465
-
Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections. Antimicrob Agents Chemother. 2017 08; 61(8).
Score: 0.121
-
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain. Antimicrob Agents Chemother. 2017 11; 61(11).
Score: 0.031